Welcome to Cinderella Therapeutics

Cinderella Therapeutics Foundation is a first in the Netherlands, and possibly in the world: a not-for-profit organization seeking to develop new drugs or therapies for patients at an affordable price. Cinderella focuses exclusively on promising therapies ignored by commercial enterprises due to their poor potential for generating revenues. Cinderella calls such inventions ‘stepchild’ drugs or therapies. The founders of Cinderella believe that stepchild therapies can be revived and brought to rapid clinical applications by abandoning the profit principle and by selecting promising projects. Each study is directed by physician/scientists and focused on patients. Participants are scientists at selected academic centers and philanthropists willing to provide both working capital and their talents.


The start of Cinderella received extensive attention from the media late 2010. In a few months time, we received hundreds of expressions of sympathy including declarations of support and assistance in various forms. In addition, there were many nominations of potential stepchild drugs. After thorough examination a dozen of these is considered for further development. We will regularly report on this site on the progress made and the problems that arise. We hope to ensure that interested scientists and philanthropists collaborate with us, offer solutions and submit suggestions for new projects.

Cinderella has experience and time for new projects.
Send us your stepchild


T A P E R I N G   S T R I P S      prescribing and ordering


Last updated on Dec 2, 2018

T A P E R I N G   S T R I P S
prescribing and ordering



In memoriam Dick van Bekkum


We are deeply saddened to learn of the passing of our chairman of the board.


Prof. Dirk W. van Bekkum

30 July 1925 – 17 July 2015


Dick set up the Cinderella Therapeutics Foundation in 2009 and was its inspiring leader from the very beginning. He was convinced of making a valuable contribution to health care by focusing specifically on the needs of patients. Developing ‘stepchild’ drugs and therapies, outside the sphere of interest of mainstream industry, is the aim of the foundation to which Dick devoted himself with great enthusiasm and in his characteristically original, creative and tenacious manner.


He will be sorely missed by us all.


Board and supporters of Cinderella Therapeutics